Particle Engineering for Drug Delivery Applications, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 218
Special Issue Editors
Interests: particle engineering; drug delivery; tissue engineering; nanocomposite microparticles; pulmonary drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: nanoparticle-based drug delivery systems; long acting parenterals; topical dosage forms; in vitro dissolution testing; in vitro and in vivo correlation; quality control
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Particle engineering has been increasingly used to prepare active pharmaceutical ingredients (APIs) for drug product formulation and drug delivery applications, for oral solid and inhaled particle formulations. The production and performance of such formulations can be greatly impacted by the given excipients and APIs, in addition to interactions between these components. Particle engineering results in the controlled production of drug particles with optimized size, morphology, and structure, using a wide variety of formulation and post-processing techniques. Potential goals for these techniques include narrow particle size distribution, improved dispersibility, enhanced stability and bioavailability, sustained release, or specific targeting. As a result, many drug delivery formulations utilize particle engineering technology. While particle engineering has been used to increase bioavailability in oral solid-dose medications, it can be translated into a variety of applications, including intravenous nanoparticles, topical particle formulations, aerosol particle formulations, etc. The aim of this Special Issue is to highlight recent advances in particle engineering applications, in relation to pharmaceutical-based particle systems. Particle-based systems that investigate a variety of formulation and/or processing parameters and their impact on the particle properties will be considered. Moreover, scientific approaches related to design of fit, particle formation, structure, and functional performance are welcome, including experimental and theoretical or modelling approaches.
Dr. Samantha Meenach
Dr. Jie Shen
Dr. Irene Andreu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- particle engineering
- drug delivery applications
- particle formulations
- engineering microparticles and nanoparticles
- advanced manufacturing technologies
- design of experiment
